• Mashup Score: 7
    One in four pharma status reports on follow-up trials are late or aren't filed - 2 year(s) ago

    “It’s one thing not to start a trial… But it’s another thing not to send in status reports. That’s a complete failure of management.”

    Source: STAT
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of pash22
      pash22

      One in four pharma status reports on follow-up trials are late or aren’t filed https://t.co/rOsH7UKpxd via @pharmalot

    • Profile photo of pharmalot
      pharmalot

      One in four pharma status reports on follow-up trials are late or aren’t filed.. https://t.co/ldgE2lAQsd #pharma #biotech #clinicaltrials #FDA #acceleratedapproval

  • Mashup Score: 1
    Gautam Mehta on Precision Oncology An Overview of the Accelerated Approval Program - The ASCO Post - 2 year(s) ago

    AACR Annual Meeting 2022 Gautam Mehta, MD, of the U.S. Food and Drug Administration, discusses how accelerated approval of potentially life-saving cancer therapies has been applied in precision oncology. Although “fast-tracking” drugs presents opportunities and challenges, one possible measure of the program’s success is the fact that, to date, no…

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      OCE's Gautam Mehta, MD, discusses how accelerated approval of potentially life-saving cancer therapies has been applied in precision oncology - via @ASCOPost #AACR22 #acceleratedapproval #OCEProjectConfirm https://t.co/u50DaJn7ST

  • Mashup Score: 0
    Project Confirm - 2 year(s) ago

    Promoting the transparency of Accelerated Approval for oncology indications

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      FDA's Accelerated Approval is 30 years old this year. The first #AcceleratedApproval in oncology was granted on October 4, 1995, to bicalutamide in combination with an LHRH analogue for advanced #prostatecancer. Learn more with #OCEProjectConfirm 👇 https://t.co/SByEFforxu https://t.co/4IQf3KnEPJ

  • Mashup Score: 3
    Project Confirm - 2 year(s) ago

    Promoting the transparency of Accelerated Approval for oncology indications

    Source: U.S. Food and Drug Administration
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VivekSubbiah
      VivekSubbiah

      ⭐️ To date, most Accelerated Approvals have been granted for oncology indications. #AcceleratedApproval was first developed in 1992 in response to the HIV/AIDS crisis? Project Confirm @FDAOncology @GautamMehtaMD @tmprowell https://t.co/bAU0vcyQ3G

  • Mashup Score: 0
    Project Confirm - 2 year(s) ago

    Promoting the transparency of Accelerated Approval for oncology indications

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      To date, most Accelerated Approvals have been granted for oncology indications, but did you know that #AcceleratedApproval was first developed in 1992 in response to the HIV/AIDS crisis? Learn more with #OCEProjectConfirm 👇 https://t.co/SByEFforxu https://t.co/bTZwJrReaQ

  • Mashup Score: 1
    Project Confirm - 2 year(s) ago

    Promoting the transparency of Accelerated Approval for oncology indications

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      The goal of #AcceleratedApproval is to provide earlier access to drugs and biologics based on initial evidence of safety and effectiveness. Learn how we work to accomplish this with #OCEProjectConfirm: https://t.co/SByEFforxu https://t.co/jfafkA26vF

  • Mashup Score: 10
    Project Confirm - 2 year(s) ago

    Promoting the transparency of Accelerated Approval for oncology indications

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      OCE Project Confirm launched a public database of oncology Accelerated Approvals to promote the transparency of outcomes related to #AcceleratedApproval for oncology indications. Learn more with #OCEProjectConfirm: https://t.co/SByEFforxu https://t.co/JcrbCBTSOW

Load More